Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 3b, Open-Label Treatment Extension study of Upadacitinib For The Treatment of Adult Subjects With Moderate to Severe Atopic Dermatitis Who Completed Treatment in Study M16-046


Collapse Overview 
Collapse sponsor award id
M16-046


Collapse Biography 

Collapse Time 
Collapse start date
2020-09-30

Collapse end date
2030-10-11